Loading…

Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure

Both diabetes mellitus (DM) and hepatitis C virus infection (HCVI) are associated with chronic kidney disease (CKD). The aim of this study was to evaluate whether HCVI increases the risk of end-stage renal disease (ESRD) in patients with DM.The National Health Insurance Research database of Taiwan w...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore) 2016-01, Vol.95 (3), p.e2431-e2431
Main Authors: Hwang, Jyh-Chang, Jiang, Ming-Yan, Lu, Yi-Hua, Weng, Shih-Feng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5165-b6c015500c8aab42b6c09bb4dd9a3d45ebc189866e3f8b692cbf786c30ec52213
cites cdi_FETCH-LOGICAL-c5165-b6c015500c8aab42b6c09bb4dd9a3d45ebc189866e3f8b692cbf786c30ec52213
container_end_page e2431
container_issue 3
container_start_page e2431
container_title Medicine (Baltimore)
container_volume 95
creator Hwang, Jyh-Chang
Jiang, Ming-Yan
Lu, Yi-Hua
Weng, Shih-Feng
description Both diabetes mellitus (DM) and hepatitis C virus infection (HCVI) are associated with chronic kidney disease (CKD). The aim of this study was to evaluate whether HCVI increases the risk of end-stage renal disease (ESRD) in patients with DM.The National Health Insurance Research database of Taiwan was used to conduct this study. After excluding patients with a prior history of CKD, all patients with a first diagnosis of DM from January 1, 2000 to December 31, 2002 were enrolled. The patients who also had HCVI were defined as index cases (HCV group, n = 9787). A comparison cohort at a 1:1 ratio of random incident patients with DM without HCVI matched by age, sex, age at the diagnosis of DM, duration between the diagnosis of DM and the index date, and various comorbidities through propensity score matching were recruited (non-HCV group, n = 9787). The patients were followed until December 31, 2011.The cumulative incidence rate of developing ESRD was significantly higher in the HCV(+) group than in the non-HCV group (P = 0.008). The incidence rate ratio (IRR) for the risk of ESRD was also significantly higher in the HCV(+) group (IRR: 1.44; 95% CI: 1.09-1.89) than in the non-HCV group, especially for those with a younger age (
doi_str_mv 10.1097/MD.0000000000002431
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4998248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1761468361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5165-b6c015500c8aab42b6c09bb4dd9a3d45ebc189866e3f8b692cbf786c30ec52213</originalsourceid><addsrcrecordid>eNpdUV1rFDEUDaLYtfoLBMmjL1PzPcmLILutXWhRtPoaksydbuzsZJtkLP57Z91aquFCuOeec-6Fg9BrSk4oMe27y9UJefSY4PQJWlDJVSONEk_RYgZl05pWHKEXpfwghPKWiefoiClNW92KBbpab3cuVJx6fL78jtdjD6HGNOK5VtF5qFDwZ1cjjLXgPmVcN4C_xHKzl5yOXfO1uusZgdEN-MzFYcrwEj3r3VDg1f1_jL6dnV4tz5uLTx_Xyw8XTZBUycarQKiUhATtnBds3xvvRdcZxzshwQeqjVYKeK-9Miz4vtUqcAJBMkb5MXp_8N1NfgtdmG_MbrC7HLcu_7LJRfvvZIwbe51-WmGMZkLPBm_vDXK6naBUu40lwDC4EdJULG0VFUpztd_FD9SQUykZ-oc1lNh9HvZyZf_PY1a9eXzhg-ZvADNBHAh3aaiQy80w3UG2G3BD3fzxk61hDSNUEUoNaWZkjvg35CCU9A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1761468361</pqid></control><display><type>article</type><title>Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><source>PubMed Central(OpenAccess)</source><source>IngentaConnect Journals</source><creator>Hwang, Jyh-Chang ; Jiang, Ming-Yan ; Lu, Yi-Hua ; Weng, Shih-Feng</creator><creatorcontrib>Hwang, Jyh-Chang ; Jiang, Ming-Yan ; Lu, Yi-Hua ; Weng, Shih-Feng</creatorcontrib><description>Both diabetes mellitus (DM) and hepatitis C virus infection (HCVI) are associated with chronic kidney disease (CKD). The aim of this study was to evaluate whether HCVI increases the risk of end-stage renal disease (ESRD) in patients with DM.The National Health Insurance Research database of Taiwan was used to conduct this study. After excluding patients with a prior history of CKD, all patients with a first diagnosis of DM from January 1, 2000 to December 31, 2002 were enrolled. The patients who also had HCVI were defined as index cases (HCV group, n = 9787). A comparison cohort at a 1:1 ratio of random incident patients with DM without HCVI matched by age, sex, age at the diagnosis of DM, duration between the diagnosis of DM and the index date, and various comorbidities through propensity score matching were recruited (non-HCV group, n = 9787). The patients were followed until December 31, 2011.The cumulative incidence rate of developing ESRD was significantly higher in the HCV(+) group than in the non-HCV group (P = 0.008). The incidence rate ratio (IRR) for the risk of ESRD was also significantly higher in the HCV(+) group (IRR: 1.44; 95% CI: 1.09-1.89) than in the non-HCV group, especially for those with a younger age (&lt;50 years; IRR: 2.05; 95% CI: 1.22-3.45) and HCVI within 4 years after the diagnosis of DM (IRR: 1.85; 95% CI: 1.16-2.97). After adjusting for comorbidities in multivariate Cox proportional hazard regression analysis, HCVI (HR: 1.47; 95% CI: 1.11-1.93) was an independent factor for developing ESRD in the patients with DM. After starting dialysis for ESRD, the HCV(+) patients had a similar mortality rate to those without HCVI (P = 0.84).HCVI increases the risk of developing ESRD in patients with DM, especially in younger patients and in those who develop HCVI sooner after a diagnosis of DM.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000002431</identifier><identifier>PMID: 26817874</identifier><language>eng</language><publisher>United States: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Adult ; Aged ; Diabetes Complications - physiopathology ; Diabetes Complications - virology ; Female ; Follow-Up Studies ; Hepacivirus - isolation &amp; purification ; Hepatitis C - physiopathology ; Hepatitis C - virology ; Humans ; Incidence ; Kidney Failure, Chronic - virology ; Longitudinal Studies ; Male ; Middle Aged ; Observational Study ; Propensity Score ; Proportional Hazards Models ; Risk Factors ; Taiwan</subject><ispartof>Medicine (Baltimore), 2016-01, Vol.95 (3), p.e2431-e2431</ispartof><rights>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><rights>Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5165-b6c015500c8aab42b6c09bb4dd9a3d45ebc189866e3f8b692cbf786c30ec52213</citedby><cites>FETCH-LOGICAL-c5165-b6c015500c8aab42b6c09bb4dd9a3d45ebc189866e3f8b692cbf786c30ec52213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998248/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998248/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26817874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hwang, Jyh-Chang</creatorcontrib><creatorcontrib>Jiang, Ming-Yan</creatorcontrib><creatorcontrib>Lu, Yi-Hua</creatorcontrib><creatorcontrib>Weng, Shih-Feng</creatorcontrib><title>Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>Both diabetes mellitus (DM) and hepatitis C virus infection (HCVI) are associated with chronic kidney disease (CKD). The aim of this study was to evaluate whether HCVI increases the risk of end-stage renal disease (ESRD) in patients with DM.The National Health Insurance Research database of Taiwan was used to conduct this study. After excluding patients with a prior history of CKD, all patients with a first diagnosis of DM from January 1, 2000 to December 31, 2002 were enrolled. The patients who also had HCVI were defined as index cases (HCV group, n = 9787). A comparison cohort at a 1:1 ratio of random incident patients with DM without HCVI matched by age, sex, age at the diagnosis of DM, duration between the diagnosis of DM and the index date, and various comorbidities through propensity score matching were recruited (non-HCV group, n = 9787). The patients were followed until December 31, 2011.The cumulative incidence rate of developing ESRD was significantly higher in the HCV(+) group than in the non-HCV group (P = 0.008). The incidence rate ratio (IRR) for the risk of ESRD was also significantly higher in the HCV(+) group (IRR: 1.44; 95% CI: 1.09-1.89) than in the non-HCV group, especially for those with a younger age (&lt;50 years; IRR: 2.05; 95% CI: 1.22-3.45) and HCVI within 4 years after the diagnosis of DM (IRR: 1.85; 95% CI: 1.16-2.97). After adjusting for comorbidities in multivariate Cox proportional hazard regression analysis, HCVI (HR: 1.47; 95% CI: 1.11-1.93) was an independent factor for developing ESRD in the patients with DM. After starting dialysis for ESRD, the HCV(+) patients had a similar mortality rate to those without HCVI (P = 0.84).HCVI increases the risk of developing ESRD in patients with DM, especially in younger patients and in those who develop HCVI sooner after a diagnosis of DM.</description><subject>Adult</subject><subject>Aged</subject><subject>Diabetes Complications - physiopathology</subject><subject>Diabetes Complications - virology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hepacivirus - isolation &amp; purification</subject><subject>Hepatitis C - physiopathology</subject><subject>Hepatitis C - virology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kidney Failure, Chronic - virology</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Observational Study</subject><subject>Propensity Score</subject><subject>Proportional Hazards Models</subject><subject>Risk Factors</subject><subject>Taiwan</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpdUV1rFDEUDaLYtfoLBMmjL1PzPcmLILutXWhRtPoaksydbuzsZJtkLP57Z91aquFCuOeec-6Fg9BrSk4oMe27y9UJefSY4PQJWlDJVSONEk_RYgZl05pWHKEXpfwghPKWiefoiClNW92KBbpab3cuVJx6fL78jtdjD6HGNOK5VtF5qFDwZ1cjjLXgPmVcN4C_xHKzl5yOXfO1uusZgdEN-MzFYcrwEj3r3VDg1f1_jL6dnV4tz5uLTx_Xyw8XTZBUycarQKiUhATtnBds3xvvRdcZxzshwQeqjVYKeK-9Miz4vtUqcAJBMkb5MXp_8N1NfgtdmG_MbrC7HLcu_7LJRfvvZIwbe51-WmGMZkLPBm_vDXK6naBUu40lwDC4EdJULG0VFUpztd_FD9SQUykZ-oc1lNh9HvZyZf_PY1a9eXzhg-ZvADNBHAh3aaiQy80w3UG2G3BD3fzxk61hDSNUEUoNaWZkjvg35CCU9A</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Hwang, Jyh-Chang</creator><creator>Jiang, Ming-Yan</creator><creator>Lu, Yi-Hua</creator><creator>Weng, Shih-Feng</creator><general>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160101</creationdate><title>Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure</title><author>Hwang, Jyh-Chang ; Jiang, Ming-Yan ; Lu, Yi-Hua ; Weng, Shih-Feng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5165-b6c015500c8aab42b6c09bb4dd9a3d45ebc189866e3f8b692cbf786c30ec52213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Diabetes Complications - physiopathology</topic><topic>Diabetes Complications - virology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hepacivirus - isolation &amp; purification</topic><topic>Hepatitis C - physiopathology</topic><topic>Hepatitis C - virology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kidney Failure, Chronic - virology</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Observational Study</topic><topic>Propensity Score</topic><topic>Proportional Hazards Models</topic><topic>Risk Factors</topic><topic>Taiwan</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hwang, Jyh-Chang</creatorcontrib><creatorcontrib>Jiang, Ming-Yan</creatorcontrib><creatorcontrib>Lu, Yi-Hua</creatorcontrib><creatorcontrib>Weng, Shih-Feng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hwang, Jyh-Chang</au><au>Jiang, Ming-Yan</au><au>Lu, Yi-Hua</au><au>Weng, Shih-Feng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>95</volume><issue>3</issue><spage>e2431</spage><epage>e2431</epage><pages>e2431-e2431</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>Both diabetes mellitus (DM) and hepatitis C virus infection (HCVI) are associated with chronic kidney disease (CKD). The aim of this study was to evaluate whether HCVI increases the risk of end-stage renal disease (ESRD) in patients with DM.The National Health Insurance Research database of Taiwan was used to conduct this study. After excluding patients with a prior history of CKD, all patients with a first diagnosis of DM from January 1, 2000 to December 31, 2002 were enrolled. The patients who also had HCVI were defined as index cases (HCV group, n = 9787). A comparison cohort at a 1:1 ratio of random incident patients with DM without HCVI matched by age, sex, age at the diagnosis of DM, duration between the diagnosis of DM and the index date, and various comorbidities through propensity score matching were recruited (non-HCV group, n = 9787). The patients were followed until December 31, 2011.The cumulative incidence rate of developing ESRD was significantly higher in the HCV(+) group than in the non-HCV group (P = 0.008). The incidence rate ratio (IRR) for the risk of ESRD was also significantly higher in the HCV(+) group (IRR: 1.44; 95% CI: 1.09-1.89) than in the non-HCV group, especially for those with a younger age (&lt;50 years; IRR: 2.05; 95% CI: 1.22-3.45) and HCVI within 4 years after the diagnosis of DM (IRR: 1.85; 95% CI: 1.16-2.97). After adjusting for comorbidities in multivariate Cox proportional hazard regression analysis, HCVI (HR: 1.47; 95% CI: 1.11-1.93) was an independent factor for developing ESRD in the patients with DM. After starting dialysis for ESRD, the HCV(+) patients had a similar mortality rate to those without HCVI (P = 0.84).HCVI increases the risk of developing ESRD in patients with DM, especially in younger patients and in those who develop HCVI sooner after a diagnosis of DM.</abstract><cop>United States</cop><pub>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>26817874</pmid><doi>10.1097/MD.0000000000002431</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2016-01, Vol.95 (3), p.e2431-e2431
issn 0025-7974
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4998248
source HEAL-Link subscriptions: Lippincott Williams & Wilkins; PubMed Central(OpenAccess); IngentaConnect Journals
subjects Adult
Aged
Diabetes Complications - physiopathology
Diabetes Complications - virology
Female
Follow-Up Studies
Hepacivirus - isolation & purification
Hepatitis C - physiopathology
Hepatitis C - virology
Humans
Incidence
Kidney Failure, Chronic - virology
Longitudinal Studies
Male
Middle Aged
Observational Study
Propensity Score
Proportional Hazards Models
Risk Factors
Taiwan
title Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A18%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20HCV%20Infection%20on%20Diabetes%20Patients%20for%20the%20Risk%20of%20End-Stage%20Renal%20Failure&rft.jtitle=Medicine%20(Baltimore)&rft.au=Hwang,%20Jyh-Chang&rft.date=2016-01-01&rft.volume=95&rft.issue=3&rft.spage=e2431&rft.epage=e2431&rft.pages=e2431-e2431&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000002431&rft_dat=%3Cproquest_pubme%3E1761468361%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5165-b6c015500c8aab42b6c09bb4dd9a3d45ebc189866e3f8b692cbf786c30ec52213%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1761468361&rft_id=info:pmid/26817874&rfr_iscdi=true